Stock Movers: Kohl's CEO Fired, Eli Lilly's Drug Loses CVS Deal, Microsoft Surges on Cloud and AI

Kohl's Leadership Shakeup

• 💡 Kohl's shares saw a significant rise, up about 7%, following the news of CEO Ashley Buchanan's removal.
• ⚠️ The board discovered Buchanan directed millions in business with an individual with whom he had a personal relationship, under "highly unusual terms," and failed to disclose this relationship.
• 📉 Despite the stock's recent jump, Kohl's shares are down approximately 49% year-to-date, indicating a challenging year for the company.
• 📌 An interim CEO has been appointed from the company's board to lead during the search for a permanent replacement.

Eli Lilly Faces Setback with CVS

• 🎯 Eli Lilly's shares experienced a notable drop, falling around 8%, due to CVS Health's decision to drop their weight-loss drug Zepbound.
• ⚡ CVS plans to instead offer rival Novo Nordisk's drug, Wegovy, a move that negatively impacts Eli Lilly's market position.
• 📈 In contrast, Novo Nordisk shares saw a slight increase of about 0.5% on this news.
• 📊 Eli Lilly's stock has gained 7% this year, while Novo Nordisk's stock has fallen 22% prior to this development.

Microsoft's Strong Performance Driven by Cloud and AI

• 🚀 Microsoft shares climbed approximately 2%, contributing to the strength of the information technology sector and pushing indexes higher.
• ✅ This surge follows stronger-than-expected third-quarter results, with total revenue reaching $70.1 billion, a 13% increase.
• ☁️ The company's cloud business was a key highlight, demonstrating sustained customer demand despite economic turbulence.
• 🧠 Microsoft's AI services are significantly contributing to Azure's growth, with AI's contribution up 16 points from 13 points in the previous quarter.